Maybe the tunable CAR-Ts of ZIOP will work. In theory, it should minimize problems with the constitutive CAR-Ts. In seems like the problems with constitutive CAR-Ts should have been anticipated, and brilliant minds should have designed tunable promoters right away and not even waste resources on constitutive CAR-Ts.
There is no good data yet on how well ADCs will work for solid tumors. I'm starting to doubt how great Kadcyla is for BC. Maybe ADCs might be more effective against solid tumors if used with HALO's hyaluronidase.
The ? after 50M tells you that I was being too lazy to look up the exact number and that I want you to look it up for me! Ha!
150 days should be this coming week. Maybe I should also put a ? after that.
I've been waiting to add except that it is about time for equity offering. This takes away people's immediate concern about the need for that stock offering. Back to $6 tomorrow. It would be nice if it touches or passes the 52-week high.
I want to see 30, but I also want my wife to be convinced right now that I am wise biotech stock picker, or else she would stop lending me money to cover my margin calls.
Anyway, if nothing happens to China, Greece, or Russia, I see $6-7 at least by the 2nd week of June.